TILT Holdings (TLLTF) Cash from Investing Activities (2021 - 2025)
TILT Holdings (TLLTF) reported Cash from Investing Activities of $47000.0 for Q2 2025, down 72.67% on a YoY basis from $172000.0 in Q2 2024, and up 102.25% quarter-over-quarter from -$2.1 million in Q1 2025.
TILT Holdings (TLLTF) Cash from Investing Activities (2021 - 2025) Analysis & Trends
TILT Holdings has reported Cash from Investing Activities for 5 years, with the latest figure at $47000.0 in Q2 2025.
- For the quarter ending Q2 2025, Cash from Investing Activities fell 72.67% year-over-year to $47000.0; the trailing twelve-month figure through Jun 2025 stood at -$2.8 million (down 317.33% YoY), and the FY2024 full-year result was -$742000.0, down 105.63% from the prior year.
- Cash from Investing Activities for Q2 2025 stood at $47000.0, up from -$2.1 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $12.8 million in Q1 2023, with the low at -$14.0 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$471125.0 across 5 years, with a median of -$364500.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 1753.68% — and 2025, when it tumbled 1029.19%.
- TILT Holdings' Cash from Investing Activities stood at -$955000.0 in 2021, then gained by 8.38% to -$875000.0 in 2022, then soared by 91.66% to -$73000.0 in 2023, then slumped by 298.63% to -$291000.0 in 2024, then soared by 116.15% to $47000.0 in 2025.
- The last three Cash from Investing Activities figures came in at $47000.0 (Q2 2025), -$2.1 million (Q1 2025), and -$291000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | -2.09 Mn |
| Mar 31, 2025 | -2.09 Mn |
| Dec 31, 2024 | -291,000.00 |
| Dec 31, 2024 | -291,000.00 |
| Sep 30, 2024 | -438,000.00 |
| Sep 30, 2024 | -438,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | -185,000.00 |
| Mar 31, 2024 | -185,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Sep 30, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | -934,000.00 |
| Jun 30, 2023 | -934,000.00 |
| Mar 31, 2023 | 12.82 Mn |
| Mar 31, 2023 | 12.82 Mn |